MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 53 filers reported holding MEI PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,000 | -17.4% | 13,316 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $23,000 | +27.8% | 13,316 | 0.0% | 0.01% | +28.6% |
| Q2 2016 | $18,000 | +5.9% | 13,316 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $17,000 | -19.0% | 13,316 | 0.0% | 0.01% | -20.0% |
| Q4 2015 | $21,000 | -12.5% | 13,316 | -13.5% | 0.01% | -16.7% |
| Q3 2015 | $24,000 | -7.7% | 15,399 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $26,000 | -7.1% | 15,399 | 0.0% | 0.01% | -7.7% |
| Q1 2015 | $28,000 | -57.6% | 15,399 | 0.0% | 0.01% | -60.6% |
| Q4 2014 | $66,000 | -25.8% | 15,399 | +19.4% | 0.03% | -31.2% |
| Q3 2014 | $89,000 | +8.5% | 12,899 | +0.0% | 0.05% | +11.6% |
| Q2 2014 | $82,000 | -44.6% | 12,896 | -2.7% | 0.04% | -50.6% |
| Q1 2014 | $148,000 | +39.6% | 13,253 | 0.0% | 0.09% | +24.3% |
| Q4 2013 | $106,000 | -40.8% | 13,253 | -16.8% | 0.07% | -45.7% |
| Q3 2013 | $179,000 | +57.0% | 15,931 | 0.0% | 0.13% | +55.4% |
| Q2 2013 | $114,000 | – | 15,931 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,039,038 | $9,482,000 | 7.48% |
| Asymmetry Capital Management, L.P. | 787,359 | $2,457,000 | 1.58% |
| First Light Asset Management, LLC | 3,763,804 | $11,743,000 | 1.20% |
| NEA Management Company, LLC | 8,533,072 | $26,623,000 | 1.13% |
| Opaleye Management Inc. | 1,556,000 | $4,855,000 | 0.95% |
| BVF INC/IL | 4,080,162 | $12,730,000 | 0.69% |
| DAFNA Capital Management LLC | 666,000 | $2,078,000 | 0.68% |
| CAXTON CORP | 175,560 | $548,000 | 0.52% |
| Alambic Investment Management, L.P. | 12,500 | $39,000 | 0.43% |
| Boxer Capital, LLC | 2,913,091 | $9,089,000 | 0.31% |